Lexington, MA and Amsterdam, the Netherlands, December 2, 2016 - uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced its participation in two panel discussions at the 2016 Genetic Rx Conference taking place at the Harvard Medical School, in Boston, MA, on December 8, 2016.
Both Harald Petry, Ph.D. and Christian Meyer, MD, Ph.D. are among several industry leaders to co-host the Genetic Rx Conference and each also will participate in the following panel discussions:
• Key Collaborations with Academia
Participating: Harald Petry, PhD - Chief Scientific Officer
Time slot: Thursday, December 8th, 2:15 p.m. EST
• Engaging Regulators, When and How?
Participating: Christian Meyer, MD, PhD - Chief Medical Officer
Time slot: Thursday, December 8th, 3.30 p.m. EST
About uniQure
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with liver/metabolic, central nervous system and cardiovascular diseases. www.uniQure.com
